Bank of Nova Scotia Cuts Stake in Amgen by Over 50%
Bank of Nova Scotia has reduced its stake in Amgen Inc., selling 158,139 shares in the second quarter. This cut represents a 50.3% decrease in the bank's holdings in Amgen.
The firm now owns 156,088 shares of Amgen stock, valued at $56,521,000 as of its most recent filing with the SEC.
This move is part of a broader trend of institutional investors and hedge funds adjusting their positions in Amgen. Anfield Capital Management LLC, for instance, boosted its stake by 1,000% in the fourth quarter.